Dow Jones

40 544,96

-0,11%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
TetraLogic Pharmaceuticals Corporation (CE) (TLOG)
TetraLogic Pharmaceuticals Corporation (CE) (TLOG) Actualités

TLOG

TetraLogic Pharmaceuticals (CE) (TLOG)

TetraLogic Pharmaceuticals Corporation (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:TLOG

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/02/2021	12h30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
27/06/2018	22h26	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
04/08/2017	21h20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	22h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	22h29	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	22h27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	18h13	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	18h11	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/11/2016	21h30	GlobeNewswire Inc.	TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible ...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
28/04/2016	12h21	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
16/03/2016	22h19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
10/02/2016	20h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/01/2016	22h11	GlobeNewswire Inc.	TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
09/11/2015	13h00	GlobeNewswire Inc.	TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hemat...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
04/11/2015	22h01	GlobeNewswire Inc.	TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/11/2015	13h00	GlobeNewswire Inc.	TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
25/08/2015	12h02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/05/2015	18h52	GlobeNewswire Inc.	TetraLogic Announces Termination of Public Offering	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/05/2015	16h14	GlobeNewswire Inc.	TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
01/05/2015	14h56	GlobeNewswire Inc.	TetraLogic Announces Pricing of $25 Million Public Offering	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
30/04/2015	22h01	GlobeNewswire Inc.	TetraLogic Announces Public Offering of Common Stock	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
21/04/2015	14h00	GlobeNewswire Inc.	TetraLogic Announces Publication of Two Papers Describing Birinapant's Preclinical Activity in Chronic Hepatitis B	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
20/04/2015	14h00	GlobeNewswire Inc.	TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid ...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
09/04/2015	16h11	GlobeNewswire Inc.	TetraLogic to Present at the 14th Annual Needham Healthcare Conference	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
30/03/2015	20h50	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
26/02/2015	22h10	GlobeNewswire Inc.	TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
26/02/2015	17h48	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
17/02/2015	21h33	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
16/01/2015	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/01/2015	18h57	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)